Categories
Cardiovascular
Diagnostics
Endocrinology
Health Insurance
Medical Devices
Mental Health
Nutrition
Oncology
Public Health
Sexual Health
Popular Articles

Drop In U.S. Births Began Before Recession, Census Data Show
Newly released Census Bureau data show that even before the current economic recession began in September 2008, population growth among children younger than age one began to decline, the AP/Kansas City Star reports. Between July 2007 and July 2008, the number of children younger than age one in the U.S. increased 0.9%, compared with a record 2.7% increase the previous year. Although births tend to drop during economic downturns as more people decide that they cannot afford to support children, experts said it is not clear why the recent drop began months before the current recession emerged. Stephanie Ventura, a demographer for the National Center for Health Statistics, said that it will be impossible to know what factors contributed to the change until demographic breakdowns are available later this year. The AP/Star reports that increases in teenage births had been driving up birth rates in recent years.Historically, birth rates have declined during poor economic times -- including the recessions of 1973, 1982 and 2001 -- and births dropped nearly 26% during the Great Depression. Mark Mather, an associate vice president at the Population Research Bureau, said, "The economy does matter. If prospects look worse for families, they"re going to be very likely to have fewer kids" (Yen/Wagster Pettus, AP/Kansas City Star, 5/19).
generic viagra online
Finding The Right Connection After Spinal Cord Injury
In a major step in spinal cord injury research, scientists at the University of California, San Diego School of Medicine have demonstrated that regenerating axons can be guided to their correct targets and re-form connections after spinal cord injury. Their findings were published in the advance online edition of the journal Nature Neuroscience on August 2.
News of the day
WHO Antivirals Arrive In Nigeria
Tamiflu
Public Health

Heart Tissue Repaired By Injecting Adult Bone Marrow Stem Cells Into Skeletal Muscle

University at Buffalo researchers have demonstrated for the first time that injecting adult bone marrow stem cells into skeletal muscle can repair cardiac tissue, reversing heart failure. Using an animal model, the researchers showed that this non-invasive procedure increased myocytes, or heart cells, by two-fold and reduced cardiac tissue injury by 60 percent. The therapy also improved function of the left ventricle, the primary pumping chamber of the heart, by 40 percent and reduced fibrosis, the hardening of the heart lining that impairs its ability to contract, by up to 50 percent. "This work demonstrates a novel non-invasive mesenchymal stem cell (MSC) therapeutic regimen for heart failure based on an intramuscular delivery route," said Techung Lee, Ph.D., UB associate professor of biochemistry and senior author on the paper. Mesenchymal stem cells are found in the bone marrow and can differentiate into a variety of cell types. "Injecting MSCs or factors released by MSCs improved ventricular function, promoted myocardial regeneration, lessened apoptosis (cell death) and fibrotic remodeling, recruited bone marrow progenitor cells and induced myocardial expression of multiple growth factor genes," Lee said. "These findings highlight the critical "cross-talks" between the injected MSCs and host tissues, culminating in effective cardiac repair for the failing heart." The paper reporting this development appears online in the Articles-in-Press section of the American Journal of Physiology -- Heart Circulation Physiology. The heart disease death rate has dropped significantly in the last three decades due to better treatments, resulting in large numbers of people living with heart failure. This advance has lead to another health hurdle: The only therapy available to reverse the decline in cardiac function is heart transplantation, and donor hearts are very scarce. Clinical trials of myocardial stem cell therapy traditionally have relied on surgery -- infusing the stem cells directly into the heart or injecting them into the myocardium, the heart muscle -- invasive methods that can result in harmful scar tissue, arrhythmia, calcification or small vessel blockages. "In our research with a swine model of heart failure," said Lee, "we"ve found that only 1-to-2 percent of MSCs infused into the myocardium grafted into the heart, and there was no evidence that they differentiated into heart muscle cells. In addition, diseased tissue is not a healthy environment for cell growth. "For these reasons, and because patients with heart failure are not good surgical risks, it made sense to explore a non-invasive cell delivery approach," said Lee. "An important feature of MSCs is their ability to produce a plethora of tissue healing effects, known as "tropic factors," which can be harnessed for stem cell therapy for heart failure. Lee noted that the multiple trophic factors produced by MSCs have been shown in the literature to be capable of reducing tissue injury, inhibiting fibrosis, promoting angiogenesis, stimulating recruitment and proliferation of tissue stem cells, and reducing inflammatory oxidative stress, a common cause of cardiovascular disease and heart failure. "Since skeletal muscle is the most abundant tissue in the body and can withstand repeated injection of large number of stem cells, we thought it would be a good method to deliver MSCs," Lee said. "We hypothesized that MSCs, via secretion of these functionally synergistic trophic factors, would be able to rescue the failing heart even when delivered away from the myocardium. "This study proves our hypothesis," said Lee. "We"ve demonstrated that injecting MSCs, or trophic factors released by MSCs, into skeletal muscle improved ventricular function, promoted regeneration of heart tissue, decreased cell death and improved other factors that cause heart failure. "This non-invasive stem cell administration regimen, if validated clinically, is expected to facilitate future stem cell therapy for heart failure." Lee said the next step is to use genetic and pharmacological engineering to make the stem cells more active, so good therapeutic effects can be achieved with fewer cells. "That is our goal. It would reduce the cost of stem cell therapy and make it more affordable for patients in the future." Arsalan Shabbir and David Zisa, graduate students in UB"s M.D./Ph.D. Medical Science Training Program, and Gen Suzuki, Ph.D., research scientist in the UB Center for Research in Cardiovascular Medicine, Department of Medicine, also contributed to the research. The work was supported by grants from the National Institutes of Health and New York State Stem Cell Science (NYSTEM). Lois Baker University at Buffalo


Add your comment:
Name:
Site address: http://
Your message:
Enter today\\\\'s date, 2 digits
(spam protection):

© Copyright 2009